| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +33.33% | -0.18% | +2.63% | -2.81% | -0.83% | — |
| 14d | 3 | +33.33% | +0.28% | +4.58% | -4.30% | -0.49% | — |
| 30d | 3 | +33.33% | -3.85% | +7.49% | -11.33% | -5.81% | — |
| 60d | 3 | +100.00% | -12.79% | +3.32% | -41.62% | -41.62% | — |
| 90d | 3 | +100.00% | -11.10% | +10.24% | -21.34% | -16.84% | — |
| 180d | 3(2 pending) | +100.00% | -45.32% | -1.11% | -44.21% | -44.21% | — |
| 1y | 3(2 pending) | +100.00% | -38.59% | +17.34% | -55.93% | -55.93% | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| IMNM IMMUNOME INC. | SALE Chief Financial Officer | 60,000 | — | — | 0 | Jun 15, 2026 | Jun 17, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | SALE10b5-1 10b5-1 plan | 60,000 | $18.23 | $1.09M | 54,037 | Jun 15, 2026 | Jun 17, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASE Chief Financial Officer | 60,000 | $1.05 | $63.0K | 114,037 | Jun 15, 2026 | Jun 17, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASE Chief Financial Officer | 39,713 | $1.35 | $53.6K | 119,037 | Apr 2, 2026 | Apr 3, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | SALE Chief Financial Officer | 39,713 | — | — | 0 | Apr 2, 2026 | Apr 3, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | SALE10b5-1 10b5-1 plan | 1,344 | $22.48 | $30.2K | 54,037 | Apr 2, 2026 | Apr 3, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASE Chief Financial Officer | 31,848 | $1.05 | $33.4K | 79,324 | Apr 2, 2026 | Apr 3, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | SALE Chief Financial Officer | 31,848 | — | — | 60,000 | Apr 2, 2026 | Apr 3, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | SALE10b5-1 10b5-1 plan | 63,656 | $21.91 | $1.39M | 55,381 | Apr 2, 2026 | Apr 3, 2026 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASEGRANT Stock grant | 207,000 | — | — | 207,000 | Jul 29, 2025 | Jul 31, 2025 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASE Chief Financial Officer | 42,000 | $1.05 | $44.1K | 61,856 | Sep 19, 2024 | Sep 19, 2024 ↗ | View → |
| IMNM IMMUNOME INC. | SALE Chief Financial Officer | 42,000 | — | — | 91,848 | Sep 19, 2024 | Sep 19, 2024 ↗ | View → |
| IMNM IMMUNOME INC. | SALE Chief Financial Officer | 14,380 | $16.01 | $230.2K | 47,476 | Sep 19, 2024 | Sep 19, 2024 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASEGRANT Stock grant | 190,000 | — | — | 190,000 | Aug 9, 2024 | Aug 13, 2024 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | May 16, 2024 | May 17, 2024 ↗ | View → |
| IMNM IMMUNOME INC. | PURCHASEGRANT Stock grant | 175,000 | — | — | 175,000 | Jan 31, 2024 | Jan 31, 2024 ↗ | View → |